New Delhi, April 16 (IANS) Certain common genetic changes may explain why some people with focal epilepsy become less responsive to seizure medications, finds a new global study.
Focal epilepsy is a condition where seizures start in one part of the brain. It is the most common type of epilepsy.
Antiseizure medication is usually prescribed for people with the condition. However, for one in three people with epilepsy (around 20 million individuals worldwide), current antiseizure medications are ineffective. This means that people will continue to have seizures despite taking medication — a condition called “drug resistance.”
It is associated with additional significant health risks in epilepsy, including a higher risk of sudden unexpected death in epilepsy, alongside substantially higher healthcare costs.
Researchers at the University College London in the UK and the University of Texas-Health Houston in the US found the reason in some specific common genetic variants in two genes: CNIH3 — which helps control how certain brain receptors function; and WDR26 — which is involved in various cell processes.
The study, published in the journal EBioMedicine showed that people with genetic variants in CNIH3 and WDR26 had a higher risk of having drug resistance in focal epilepsy. The variants also determined a person’s response to antiseizure medications.
“The findings of our study offer new insights about why some people have seizures that are resistant to existing antiseizure medications,” said Professor Sanjay Sisodiya from UCL’s Queen Square Institute of Neurology.
“Recognising these genetic variants, which are frequent in the general population yet strongly influence treatment outcomes, underscores the need to expand genetic testing and future therapies to address polygenic epilepsy (a type of epilepsy that is influenced by multiple genes),” added Costin Leu, Assistant Professor at UTHealth Houston).
For the study, the researchers examined data on 6,826 people with epilepsy.
They compared the genomes of those who had drug-resistant epilepsy (4,208 individuals) with those whose seizures were successfully controlled with antiseizure medications (2,618 individuals).
The findings are particularly important as these genetic signatures can be determined at the onset of epilepsy, rather than after several antiseizure medications have been tried without success.
This could eventually help to predict which individuals with epilepsy are likely to develop drug resistance and avoid unnecessary exposure to ineffective medications and their associated side effects, said the team.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
